相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。mTOR inhibitor rapamycin alone or combined with cisplatin inhibits growth of esophageal squamous cell carcinoma in nude mice
Guiqin Hou et al.
CANCER LETTERS (2010)
Rapamycin-Resistant mTORC1 Kinase Activity Is Required for Herpesvirus Replication
Nathaniel J. Moorman et al.
JOURNAL OF VIROLOGY (2010)
Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production
Tommy Alain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
RAPping production of type I interferon in pDCs through mTOR
Mauro Costa-Mattioli et al.
NATURE IMMUNOLOGY (2008)
Coadministration of a herpes simplex virus-2-based oncolytic virus and cyclophosphamide produces a synergistic antitumor effect and enhances tumor-specific immune responses
Hongtao Li et al.
CANCER RESEARCH (2007)
An HSV-2-based oncolytic virus deleted in the PK domain of the ICP10 gene is a potent inducer of apoptotic death in tumor cells
X. Fu et al.
GENE THERAPY (2007)
Viruses as anticancer drugs
Stephen J. Russell et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells
Marianne M. Stanford et al.
JOURNAL OF VIROLOGY (2007)
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Ta-Chiang Liu et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Serial passage through human glioma xenografts selects for a Δγ134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors
Amish C. Shah et al.
JOURNAL OF VIROLOGY (2006)
A mutant type 2 herpes simplex virus deleted for the protein kinase domain of the ICP10 gene is a potent oncolytic virus
Xinping Fu et al.
MOLECULAR THERAPY (2006)
Oncolytic virotherapy: Approaches to tumor targeting and enhancing antitumor effects
SH Thorne et al.
SEMINARS IN ONCOLOGY (2005)
Replication-selective oncolytic viruses in the treatment of cancer
B Everts et al.
CANCER GENE THERAPY (2005)
Potent antitumor activity after systemic delivery of a doubly fusogenic oncolytic herpes simplex virus against metastatic prostate cancer
M Nakamori et al.
PROSTATE (2004)
Herpes simplex virus: receptors and ligands for cell entry
PG Spear
CELLULAR MICROBIOLOGY (2004)
Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect
XP Fu et al.
MOLECULAR THERAPY (2003)
Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors
VW van Beusechem et al.
GENE THERAPY (2003)
分享论文
